AdreView

Product NDC: 17156-235
11-digit product format: 171560235
Labeler code: 17156
Product ID: 17156-235_44cadee9-19ca-4756-ab85-0836b38db89f
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Iobenguane I-123
Dosage form: INJECTION
Route: INTRAVENOUS
Labeler: Medi-Physics Inc.
Application: NDA022290
Marketing category: NDA
Marketing start: 2008-09-19
Substance: IOBENGUANE I-123
Active strength: 2 mCi/mL
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N022290-001	ADREVIEW	IOBENGUANE SULFATE I-123	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2008-09-19	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2008-09-19	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2008-09-19	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2008-09-19	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N022290-001	ADREVIEW	10mCi/5ML (2mCi/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-09-19	`e64feba35796…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022290-001	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022290-001	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022290-001	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022290-001	AP	1	`2680178bc6a6…`

Additional Listing Data#

Finished product: Yes
Brand name base: AdreView
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
IOBENGUANE I-123	2 mCi/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
P2TH1XYZ84	Internal UNII lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
c89d3ecc-4f4c-4566-8808-79152344194d	Available on FDA.report

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
17156-235-01	AdreView	1 in 1 CONTAINER	INJECTION	1		9
17156-235-01	AdreView	5 mL in 1 VIAL, GLASS	INJECTION	5		9

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
17156-235-01	EA - Each	17156-235	d60d0587-ec9e-4970-956d-304c07a5b922	2	2022-11-07

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Iobenguane I-123	ACTIVE INGREDIENT	P2TH1XYZ84	ADREVIEW (IOBENGUANE I-123) INJECTION [MEDI-PHYSICS INC.]	5
Iobenguane I-123	ACTIVE MOIETY	P2TH1XYZ84	ADREVIEW (IOBENGUANE I-123) INJECTION [MEDI-PHYSICS INC.]	5
Benzyl alcohol	INACTIVE INGREDIENT	LKG8494WBH	ADREVIEW (IOBENGUANE I-123) INJECTION [MEDI-PHYSICS INC.]	5
Sodium phosphate, dibasic, dihydrate	INACTIVE INGREDIENT	94255I6E2T	ADREVIEW (IOBENGUANE I-123) INJECTION [MEDI-PHYSICS INC.]	5
Sodium phosphate, monobasic, dihydrate	INACTIVE INGREDIENT	5QWK665956	ADREVIEW (IOBENGUANE I-123) INJECTION [MEDI-PHYSICS INC.]	5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
17156-235	ADREVIEW (IOBENGUANE I-123) INJECTION [MEDI-PHYSICS INC.]	9	Current NDC, Legacy NDC, 2 package rows	20240112_c89d3ecc-4f4c-4566-8808-79152344194d.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
AdreView	IOBENGUANE I-123	Medi-Physics Inc.	c89d3ecc-4f4c-4566-8808-79152344194d	2024-01-10	Warnings, Adverse reactions	Exact identifier application applno (NDA): 022290 application number: NDA022290 ndc (product): 17156-235

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
P2TH1XYZ84	IOBENGUANE I-123	76924-93-1	IOBENGUANE I-123

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
17156-235-01	17156023501	1 VIAL, GLASS in 1 CONTAINER (17156-235-01) / 5 mL in 1 VIAL, GLASS	2008-09-19	0000-00-00	No	No	Current